The PYGM gene helps your muscles break down stored sugar for quick energy during activity. If it does not work properly, exercise can bring early fatigue, muscle pain or cramps, and sometimes dark urine after hard exertion. Certain variants in the PYGM gene cause McArdle disease, a condition that affects how muscles use fuel. Some people notice a “second wind,” when activity feels easier after slowing down for a few minutes.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some provide the information needed to produce proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. More detailed information on this topic is available in the LearnHub.
Overview
PYGMGene function
What if the gene works
The PYGM gene helps your skeletal muscles break down stored sugar for fuel, especially during exercise. This supports quick energy for movement and helps muscles keep working during activity.
Risk
What if the gene does not work
Variants in the PYGM gene can cause McArdle disease, where muscles cannot use stored sugar well during activity. Many people develop early exercise intolerance, muscle pain or cramps, and sometimes dark urine after exertion; milder and more severe forms occur.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the PYGM gene, treatment is usually not tailored to the exact variant. Management is largely the same across PYGM-related cases and centers on paced aerobic activity, avoiding sudden intense exertion, and sometimes using a fast-acting carbohydrate before planned exercise to improve tolerance. No approved PYGM-targeted drug is currently established.
Conditions associated with PYGM
Gene function
What if the gene works
In skeletal muscle, the PYGM gene helps turn stored sugar into a usable fuel source. Its protein, called myophosphorylase, starts the process of breaking down glycogen, the storage form of glucose. This supports everyday movement and helps explain how the PYGM gene helps muscles use stored sugar during exercise.
The PYGM gene makes a protein that begins breaking glycogen into smaller sugar units inside muscle cells. This gives muscles access to fuel that is already stored and ready to use.
During activity, muscles need energy quickly, especially in the first moments of movement. PYGM supports this fast response by helping release sugar from glycogen for energy production.
By supplying fuel within muscle cells, the PYGM gene helps power muscle contraction. This is part of the normal system that supports walking, climbing stairs, and other daily movements.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can more substantially affect how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many PYGM gene variants reduce or stop production of muscle glycogen phosphorylase, or make the enzyme unstable so it breaks down early. In practical terms, PYGM gene variants and enzyme function can range from milder changes with some activity left to more severe variants that leave little or none. Variants that preserve residual activity may be linked to later onset or milder McArdle disease, while severe loss of function often brings earlier, more marked symptoms.
How variants are linked to conditions
Pathogenic variants in the PYGM gene cause glycogen storage disease type V, also called McArdle disease. This PYGM gene McArdle disease link is well established, and finding two disease-causing variants usually confirms the diagnosis. People with this condition often develop exercise intolerance, early muscle pain or cramps, and sometimes episodes of dark urine after strenuous activity. Some also develop fixed muscle weakness over time.
A variant is not necessarily a diagnosis
Genetic variants are common and make up a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PYGM-related disease, the chance of having the condition is mainly set by the gene changes inherited from your parents. In people living with it, sudden hard exercise and sometimes long gaps without food can trigger muscle pain, cramps, and dark urine. Steady, gentle activity and avoiding sudden all-out effort can help reduce episodes, but they do not remove the genetic condition.
Inheritance of PYGM variants
Variants in the PYGM gene linked to McArdle disease are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease causing PYGM gene variants, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking how PYGM gene variants are inherited, sons and daughters are affected at similar rates.
What does my PYGM result mean for my family?
For PYGM, family implications are usually based on a recessive pattern. Brothers and sisters of someone with a disease-causing PYGM result may also have the condition or be carriers, and parents are often healthy carriers. Other relatives, such as adult children or cousins, may also carry the same gene change, so the meaning for family members often centers on carrier status as well as who else might be affected.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the PYGM gene usually uses a blood or saliva sample. A lab reads the PYGM gene to look for changes linked with glycogen storage disease type V, and results can show whether you carry a disease-causing variant, two variants that confirm the diagnosis, or no relevant variant.
When should I consider getting a genetic test?
Consider PYGM testing if you or your child has severe muscle pain, cramps, or unusual tiredness soon after exercise, especially with dark urine after activity. It can also help when McArdle disease is suspected or when a close family member has a PYGM change.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies depending on the condition and the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, which can change how well it works or how likely side effects are. These differences are common and can influence how sensitive you are to a treatment, even when two people take the same medicine in the same way.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medicines. It studies the relationship between genes and medications to help explain why the same treatment may work differently in different people. With many drugs, genes influence either how powerfully a medicine works or how the body handles it. This information can support treatment choices that are better informed and more individualized. To learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the PYGM gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new medicines, or changes to treatment are best discussed with your doctor or pharmacist.
History
McArdle disease, the condition most closely linked to the PYGM gene, was first described in 1951 by British physician Brian McArdle after he recognized a pattern of exercise related muscle symptoms and unusually low lactate during activity. Initially understood only through visible traits, later recognized as tied to a specific gene, it became one of the classic inherited muscle energy conditions described in modern medicine. In the years that followed, researchers connected the condition to missing muscle glycogen phosphorylase activity. Building on this early work, scientists uncovered more about the PYGM gene and identified inherited variants responsible for the condition. These discoveries helped turn a puzzling clinical pattern into a clearly defined genetic diagnosis. Today, PYGM remains an important part of the history of metabolic muscle disease research.